Literature DB >> 25894298

Aflatoxin levels in chronic hepatitis B patients with cirrhosis or hepatocellular carcinoma in Balıkesir, Turkey.

M Aydın1, S Aydın2, M Bacanlı2, N Başaran2.   

Abstract

Aflatoxins, the secondary metabolites produced by species of naturally occurring Aspergilli, are commonly found in food such as cereals, dried fruits and juice, wine, beer and spices. They are hepatotoxic and are well known human carcinogens based on evidence from human studies. Aflatoxins are an environmental risk factor for the development of hepatocellular carcinoma (HCC). Chronic hepatitis B-infected patients are at increased risk of cirrhosis, hepatic failure and liver cancer. This study was designed to determine the serum aflatoxin B1 (AFB1 ), aflatoxin B2 (AFB2 ), aflatoxin G1 (AFG1 ) and aflatoxin G2 (AFG2 ) concentrations using high-pressure liquid chromatography (HPLC) in hepatitis B-infected patients with or without cirrhosis and liver cancer, alongside healthy controls in Balıkesir, Turkey. The mean AFB1 and total AF levels in patients without liver cancer and cirrhosis were significantly higher than healthy controls. The mean AFB1 and total AF levels in patients with chronic hepatitis B and HCC were significantly higher than infected patients with or without cirrhosis. These results suggest that patients with chronic hepatitis B who are exposed to AFs are at increased risk for developing HCC, which might be prevented by reducing consumption of contaminated foods.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  Turkey; aflatoxins; chronic hepatitis B; cirrhosis; hepatocellular carcinoma

Mesh:

Substances:

Year:  2015        PMID: 25894298     DOI: 10.1111/jvh.12410

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  9 in total

1.  Mitigation potential of individual and combined dietary supplementation of local Bentonite Clay and Distillery Sludge against Ochratoxin-A induced toxicity in broilers.

Authors:  Mian Muhammad Awais; Ujala Mehtab; Muhammad Irfan Anwar; Muhammad Raza Hameed; Masood Akhtar; Ahmad Raza; Riffat Aisha; Faqir Muhammad; Muhammad Kashif Saleemi; Ahad Fayyaz
Journal:  BMC Vet Res       Date:  2022-10-19       Impact factor: 2.792

2.  Aflatoxin B1 exposure and liver cirrhosis in Guatemala: a case-control study.

Authors:  Christian S Alvarez; Elisa Hernández; Kira Escobar; Carmen I Villagrán; María F Kroker-Lobos; Alvaro Rivera-Andrade; Joshua W Smith; Patricia A Egner; Mariana Lazo; Neal D Freedman; Eliseo Guallar; Michael Dean; Barry I Graubard; John D Groopman; Manuel Ramírez-Zea; Katherine A McGlynn
Journal:  BMJ Open Gastroenterol       Date:  2020-07

3.  Exploration of the Regulatory Mechanism of Secondary Metabolism by Comparative Transcriptomics in Aspergillus flavus.

Authors:  Guangshan Yao; Yuewei Yue; Yishi Fu; Zhou Fang; Zhangling Xu; Genli Ma; Shihua Wang
Journal:  Front Microbiol       Date:  2018-08-07       Impact factor: 5.640

4.  Human Biomonitoring of Mycotoxins in Blood, Plasma and Serum in Recent Years: A Review.

Authors:  Beatriz Arce-López; Elena Lizarraga; Ariane Vettorazzi; Elena González-Peñas
Journal:  Toxins (Basel)       Date:  2020-02-27       Impact factor: 4.546

5.  Inhibiting Th1/2 cells influences hepatic capillarization by adjusting sinusoidal endothelial fenestrae through Rho-ROCK-myosin pathway.

Authors:  Yuesi Zhong; Mingxing Xu; Jingxiong Hu; Xi Huang; Nan Lin; Meihai Deng
Journal:  Aging (Albany NY)       Date:  2021-02-01       Impact factor: 5.682

Review 6.  Distribution of Aspergillus Fungi and Recent Aflatoxin Reports, Health Risks, and Advances in Developments of Biological Mitigation Strategies in China.

Authors:  Firew Tafesse Mamo; Birhan Addisie Abate; Yougquan Zheng; Chengrong Nie; Mingjun He; Yang Liu
Journal:  Toxins (Basel)       Date:  2021-09-24       Impact factor: 4.546

7.  Genetic polymorphisms in ataxin-3 and liver cirrhosis risk related to aflatoxin B1.

Authors:  Xing-Zhizi Wang; Xiao-Ying Huang; Jin-Guang Yao; Chao Wang; Qiang Xia; Xi-Dai Long
Journal:  Oncotarget       Date:  2018-02-19

8.  Aflatoxins as a risk factor for liver cirrhosis: a systematic review and meta-analysis.

Authors:  Abraham Nigussie Mekuria; Michael N Routledge; Yun Yun Gong; Mekonnen Sisay
Journal:  BMC Pharmacol Toxicol       Date:  2020-06-01       Impact factor: 2.483

Review 9.  Mycotoxins in Ethiopia: A Review on Prevalence, Economic and Health Impacts.

Authors:  Firew Tafesse Mamo; Birhan Addisie Abate; Kassahun Tesfaye; Chengrong Nie; Gang Wang; Yang Liu
Journal:  Toxins (Basel)       Date:  2020-10-08       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.